FMP
NASDAQ
2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. Its products pipeline includes idecabtagene vicleucel; ide-cel or Abecma and bb21217; and CAR-T cell product candidates for the treatment of multiple myeloma. 2seventy bio, Inc. has a collaboration arrangement with Bristol-Myers Squibb Company. The company was incorporated in 2021 and is headquartered in Cambridge, Massachusetts.
4.65 USD
0.01 (0.215%)
Valuation Date:
Apr 19, 2024 10:21 AM
Share Price on Valuation Date
$4.65
Stock Beta
1.851
Shares Outstanding
51311130